CLINICAL LAB SCIENEC

INDEX 467
pathogen–related infection
prevention, 151
Extension cords, hazards related to,
92–93, 93f
Extrinsic factors, 328
Eye goggles, as barriers against
contamination, 122f–124f,
124–126
F
FAA. See Federal Aviation Authority
(FAA)
Face shield, as barrier against
contamination, 124–126,
124f
Factor X, 329
Faculty members, categorization of,
121–124, 122f, 123f
Fahrenheit, to Celsius, conversion of,
214, 214f
formula for, 214, 215t
“Father of Medicine,” 6
FCC. See Federal Communication
Commission (FCC)
FDA. See Food and Drug
Administration (FDA)
Fecal materials, in urine, 301
Federal Aviation Authority (FAA),
50
Federal Communication Commission
(FCC), 50
Federal Emergency Management
Agency (FEMA), 116
Federal Register, 99
Feline leukemia, 114
FEMA. See Federal Emergency Management
Agency (FEMA)
Fiber(s)
cotton, 308f
plant, 308f
Fiber fragments, in urine, 301
Figure(s), significant, 208
Fire(s), medical facility–related,
93–95, 93f–96f
categories of, 93–94, 94f
escape route for, 93, 93f
fire extinguisher availability and
location, 94–95, 95f
personal safety in, 95, 95f, 96f
safety measures in prevention of,
100–101, 101t
Fire extinguishers, 94–95, 95f
First aid supplies, Safety Committee
responsibility for, 101
Fixed volume pipettes, 202–203
Flask(s)
Erlenmeyer, 188–189, 189f
volumetric, 188, 189f
Fleming, A., in development of microbiology,
386
Flora, normal, 118, 388
Fluorescent labeling, 390
Food and Drug Administration
(FDA), 116
Forward grouping, by slide method,
424–426, 425f. See also
Immunohematology (blood
banking), direct blood or
forward grouping by slide
method
Franklin, R., in history of laboratory
medicine, 8
F-test, 248–249, 249t
Fume hood, 179, 179f
for toxic hazards, 90–91, 91f
Fungal infections, 388, 389f
Fungus(i), described, 387–388
G
Gauge(s), needle, defined, 266
Gaussian random variable
distribution, 237, 238
GDP. See Gross domestic product
(GDP)
Gene probes, 390
General Motors, in health care insurance
responsibilities, 161
Genetic manipulation, 57
Genetic predisposition, advances in,
15
Ghost cells, 303
Giardia lamblia, in urine, 301
Gilson micropipettes, 199
Glassware. See also specific devices
broken, use and disposal of, 97
plastic vs., cleanliness and use of,
187–188, 188f
use of, 185–205
introduction to, 186–188, 186f,
188f
for storage, 190–191, 191f
Glomerular permeability, 313
Glove(s), as barriers against contamination,
122f–125f, 124–126
Glucose
in CSF, determination of, 321–322
described, 372
in urine, semiquantitative test for,
311–313, 313f
Glucose levels, determination of,
372–375. See also Stanbio
Enzymatic Glucose procedure
equipment and supplies, 373
linearity in, 375
principles, 372–373
procedure, 374–375
QC, 375
reporting of results, 375
Glucose tests, daily, normal control
in, graph for, 240–241
Goggles, as barriers against contamination,
122f–124f, 124–126
Gown(s), as barriers against
contamination, 122f–125f,
124–126
Graduated cylinders, 189–190, 190f
Gram(s), 212
as measurement type, 210
Gram stain, preparation of, 397–
398, 398f
equipment and supplies, 397
principles, 397
procedure, 397–398, 398f
reporting of results, 398
“Grandfather clauses,” 53
Granular cast, 306t, 307f
Granule(s), starch, 308f
Griffin beaker, 189, 190f
Gross domestic product (GDP),
medical care portion of, 157
H
Hazard communication, in infection
control, 117
HBV. See Hepatitis, B
HCFA. See Health Care Financing
Administration (HCFA)
Hct. See Hematocrit (Hct)
HDL. See High-density lipoprotein
(HDL)
HDL Test Kit, 375–378
Health care
ethical delivery of, 63–65
Copyright 2010 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part. Due to electronic rights, some third party content may be suppressed from the eBook and/or eChapter(s).
Editorial review has deemed that any suppressed content does not materially affect the overall learning experience. Cengage Learning reserves the right to remove additional content at any time if subsequent rights restrictions require it.